Jin-huan Xu

发表

Sequential CAR T-Cell Therapy After Autologous Stem Cell Transplantation for the Treatment of Relapsed/Refractory Intravascular Large B-Cell Lymphoma With Central Nervous System Involvement: A Case Report

Wanying Liu, Chunrui Li, Yang Cao, 2022, Frontiers in Oncology.

Inflammatory signatures for quick diagnosis of life-threatening infection during the CAR T-cell therapy

N. Wang, Jianfeng Zhou, Yang Cao, 2019, Journal of Immunotherapy for Cancer.

Allogeneic Hematopoietic Stem Cell Transplantation Mobilized With Pegylated Granulocyte Colony-Stimulating Factor Ameliorates Severe Acute Graft-Versus-Host Disease Through Enrichment of Monocytic Myeloid-Derived Suppressor Cells in the Graft: A Real World Experience

Jia Wei, Yang Cao, Na Wang, 2021, Frontiers in Immunology.

A phase I study of anti‐BCMA CAR T cell therapy in relapsed/refractory multiple myeloma and plasma cell leukemia

L. Meng, Jianfeng Zhou, Tongcun Zhang, 2021, Clinical and translational medicine.

Increased plasma indoleamine 2,3-dioxygenase activity and interferon-γ levels correlate with the severity of acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.

Jia Wei, Jin-huan Xu, Yicheng Zhang, 2013, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Efficacy of Mesenchymal Stem Cell Therapy for Steroid-Refractory Acute Graft-Versus-Host Disease following Allogeneic Hematopoietic Stem Cell Transplantation: A Systematic Review and Meta-Analysis

Jia Wei, Xiaomei Chen, Jin-huan Xu, 2015, PloS one.

Case Report: Metagenomic Next-Generation Sequencing Can Contribute to the Diagnosis and Treatment of Disseminated Visceral Kaposi Sarcoma Following Allogeneic Haematopoietic Stem Cell Transplantation

Z. Shang, Jin-huan Xu, Yi Xiao, 2022, Frontiers in Oncology.

Tryptophan metabolite analog, N-(3,4-dimethoxycinnamonyl) anthranilic acid, ameliorates acute graft-versus-host disease through regulating T cell proliferation and polarization.

M. Huang, Jia Wei, Jin-huan Xu, 2013, International immunopharmacology.

Long event-free survival after anti-BCMA CAR-T cell treatment for relapsed and refractory multiple myeloma patients

Jin-huan Xu, Yi Xiao, Chunyan Wang, 2021, Medicine.

Pilot study using tacrolimus rather than cyclosporine plus antithymocyte globulin as an immunosuppressive therapy regimen option for severe aplastic anemia in adults.

Lei Zhao, Jia Wei, Jin-huan Xu, 2014, Blood cells, molecules & diseases.

Allogeneic Stem-Cell Transplantation for Peripheral T-Cell Lymphoma: A Systemic Review and Meta-Analysis

Jianfeng Zhou, Jia Wei, Yang Cao, 2014, Acta Haematologica.

The utility of non‐invasive liquid biopsy for mutational analysis and minimal residual disease assessment in extramedullary multiple myeloma

Jia Gu, Jianfeng Zhou, Chunrui Li, 2020, British journal of haematology.

Circ_0009910 shuttled by exosomes regulates proliferation, cell cycle and apoptosis of acute myeloid leukemia cells by regulating miR‐5195‐3p/GRB10 axis

Jin-huan Xu, Yi Xiao, Di Wang, 2021, Hematological oncology.

CAR T-Cell Therapy for Relapsed/Refractory Diffuse Large B-Cell Lymphoma with Progressive Muscular Dystrophy: A Case Report

Wanying Liu, Jin-huan Xu, M. Xiao, 2022, OncoTargets and therapy.

OTT_A_352760 361..366

Wanying Liu, Jin-huan Xu, M. Xiao, 2022 .

Mosaic trisomy 21 and trisomy 14 as acquired cytogenetic abnormalities without GATA1 mutation in a pediatric non-down syndrome acute megakaryoblastic leukemia

Jianfeng Zhou, Jia Wei, Jin-huan Xu, 2011, Chinese journal of cancer research = Chung-kuo yen cheng yen chiu.

Outcomes of allogeneic haematopoietic stem cell transplantation for patients with severe aplastic anaemia using the porcine antilymphocyte globulin-containing conditioning regimen

Jia Wei, Jin-huan Xu, Yicheng Zhang, 2020, Annals of Hematology.

Haploidentical Transplantation with Modified Post-transplantation Cyclophosphamide for Patients with Primary Aplastic Anemia: A Multicenter Experience.

Lin Li, Lan-lan Wang, Jia Wei, 2021, Transplantation and cellular therapy.

MYC/BCL2/BCL6 triple hit and TP53 deletion in a case of high-grade B cell lymphoma receiving CAR T cell immunotherapy

Jianfeng Zhou, Liang Huang, Z. Shang, 2021, Journal for ImmunoTherapy of Cancer.

Anti-BCMA CAR-T cells for treatment of plasma cell dyscrasia: case report on POEMS syndrome and multiple myeloma

Jianfeng Zhou, Hao Xu, Chunrui Li, 2018, Journal of Hematology & Oncology.

Autologous Stem Cell Transplantation as the First-Line Treatment for Peripheral T Cell Lymphoma: Results of a Comprehensive Meta-Analysis

J. Yin, Jin-huan Xu, Yicheng Zhang, 2013, Acta Haematologica.

Efficacy of programmed cell death 1 inhibitor maintenance after chimeric antigen receptor T cells in patients with relapsed/refractory B-cell non-Hodgkin-lymphoma.

Liang Huang, Jue Wang, Jin-huan Xu, 2024, Cellular oncology.

Prognostic differences between carmustine, etoposide, cytarabine and melphalan (BEAM) and carmustine, etoposide, cytarabine, melphalan and fludarabine (BEAMF) regimens before autologous stem cell transplantation plus chimeric antigen receptor T therapy in patients with refractory/relapsed B-cell non

Liang Huang, Jue Wang, Jin-huan Xu, 2024, Cytotherapy.

Anti-CD30 chimeric antigen receptor T cell therapy for relapsed/refractory CD30+ lymphoma patients

N. Wang, Chunrui Li, Liang Huang, 2020, Blood Cancer Journal.